The threat to scientific integrity in environmental and occupational medicine

Occupational and Environmental Medicine

Volumn 62, Issue 12, 2005, Pages 843-846

  Tong, S ^a   Olsen, J ^b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BUDGET; COMPETITION; ENVIRONMENTAL HEALTH; ETHICS; GOVERNMENT; LEGAL ASPECT; OCCUPATIONAL HEALTH; ORGANIZATION; PRIORITY JOURNAL; RESEARCH; RISK ASSESSMENT; TOBACCO INDUSTRY;

CONFLICT OF INTEREST; ENVIRONMENTAL MEDICINE; ETHICS, RESEARCH; HUMANS; LEAD; METALLURGY; OCCUPATIONAL MEDICINE; PROFESSIONAL MISCONDUCT; PUBLIC HEALTH; RESEARCH SUPPORT; TOBACCO INDUSTRY;

NICOTIANA TABACUM;

EID: 28444458542     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.2005.021410     Document Type: Article

References (42)

1. Rom W. Environmental & occupational medicine. Philadelphia: Lippincott-Raven Publishers, 1998.
2. Quinn M, Levenstein C, DeLaurier GF. Good Practice Guidelines for Occupational Health Research Funded by the Private Sector. New Solut 2001;11:303-14.
3. National Centre for Health Statistics. Health, United States, 2000. Hyattsville, MD: National Centre for Health Statistics, 2000:337.
4. Rosenstock L, Lee LJ. Attacks on science: the risks to evidence-based policy. Am J Public Health 2002;92:14-18.
5. Egilman D, Tweedale G, McCulloch J. PWJ Bartrip's attack on Irving J. Selikoff. Am J Ind Meet 2004;46:151-5.
6. Bartrip PWJ. Irving John Selikoff and the strange case of the missing medical degrees. J Hist Med Allied Sci 1993;58:3-33.
7. LaDou J. The asbestos cancer epidemic. Environ Health Perspect 2004;112:285-90.
8. Friedberg M, Saffron B, Stinson TJ, et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA, 1999 20, 282:1453-7.
9. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000;321:323-29.
10. Abdullah AS, Husten CG. Promotion of smoking cessation in developing countries: a framework for urgent public health interventions. Thorax 2004;59:623-30.
11. Yach D, Bialous SA. Junking science to promote tobacco. Am J Public Health 2001;91:1745-8.
12. Fields N, Chapman S. Chasing Ernst L Wynder: 40 years of Philip Morris efforts to influence a leading scientist. J Epidemiol Comm Health 2003;57:571-8.
13. Parascandola M. Hazardous effects of tobacco industry funding. J Epidemiol Comm Health 2003;57:548-9.
14. Jensen CO. [Letter to Dr E L Wynder, Memorial Hospital]. 7 January 1958. Lorillard. Bates Number: 00006298/6299, Available at http://legacy.library.ucsf. edu/tid/qdm51e00 (accessed 12 May 2005).
15. Spears AW. [Letter to Dr E L Wynder, Sloan-Kettering Cancer Institute]. 17 March 1962. Lorillard. Bates No. 87657326/7327. Available at http://legacy.library.ucsf.edu/tid/mnr21e00 (accessed 12 May 2005).
16. Cohen J, Ashley M, Ferrence R, et al. Institutional addiction to tobacco. Tob Control 1999;8:70-4.
17. Blum A. Ethics of tobacco-funded research in US medical schools. Tob Control 1992;1:244-5.
18. Lewison G, Dawson G, Anderson J. Support for UK biomedical research from tobacco industry. Lancet 1997;349:778.
19. Ong E, Glantz S. Tobacco industry efforts subverting International Agency for Research on Cancer's second-hand smoke study. Lancet 2000;355:1253-9.
20. International Agency for Research on Cancer. Available at http://www.iarc.fr/ENG/Press_Releases/pr158a.html (accessed 15 January 2005).
21. Garne D, Watson M, Chapman S, et al. Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry. Lancet 2005;365:804-9.
22. Peto R, Chen ZM, Boreham J. Tobacco-the growing epidemic. Nat Med 1999;5:15-17.
23. Daube M. Political history of smoking and health. Tob Control 2000;9:353-4.
24. Davis D. When smoke ran like water: tales of environmental deception and the battle against pollution. New York: Basic Books, 2002:125-33.
25. Ernhart CB, Scarr S, Geneson DF. On being a whistleblower: the Needleman case. Ethics Behav 1993;3:73-93.
26. Needleman H. A reply to Scarr and Ernhart. Pediatrics 1993;91:519-21.
27. Silbergeld EK. Annotation: protection of the public interest, allegations of scientific misconduct, and the Needleman case. Am J Public Health 1995;85:165-6.
28. Chisholm J, Goldstein G, Cory-Slechta D, et al. Lead debate goes on. Pediatrics 1994;94:408-10.
29. Kuehn R. Suppression of environmental science. Am J Law Med 2004;30:333-69.
30. McCrary SV, Anderson CB, Jakovljevic J, et al. A national survey of policies on disclosure of conflicts of interest in biometical research. N Eng J Med 2000;343:1621-6.
31. Michaels D, Wagner W. Disclosure in regulatory science. Science 2003;302:2073.
32. Moses H, Martin J. Academic relationships with industry. JAMA 2001;285:933-5.
33. Resnik DB, Shamoo AE. Conflict of interest and the university. Account Res 2002;9:45-64.
34. Union of Concerned Scientists. Available at http://www.ucsusa.org/ global_environment/rsi (accessed 10 August 2004).
35. Union of Concerned Scientists. Scientific Integrity in Policymaking. Available at http://www.ucsusa.org (accessed 18 October 2004).
36. Ashford NA, Castleman B, Frank AL, et al. The International Commission on Occupational Health (ICOH) and its influence on international organizations. Int J Occup Environ Health 2002;8:156-62.
37. Union of Concerned Scientists. Available at http://www.ucsusa.org/news (accessed 18 October 2004).
38. Union of Concerned Scientists. Available at http://www.ucsusa.org/rsi (accessed 18 October 2004).
39. Robbins A. Science policy and politics: Will the recent past preface the future? Epidemiol 2005;16:406-9.
40. Wu R. Making an impact. Nature 2004;428:206-7.
41. Poo MM. Culture reflections. Nature 2004;428:204-5.
42. Campbell P. Message to China from the west. Nature 2004;428:203.